Skip navigation
Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12439/2736
Full metadata record
DC FieldValueLanguage
dc.contributor.authorYuexia Zhao-
dc.contributor.authorArshin Ghaedi-
dc.contributor.authorPouria Azami-
dc.contributor.authorSeyed Ali Nabipoorashrafi-
dc.contributor.authorHamed Bazrafshan Drissi-
dc.contributor.authorMaryam Amin Dezfouli-
dc.contributor.authorShirin Sarejloo-
dc.contributor.authorBrandon Lucke-Wold-
dc.contributor.authorJohn Cerillo-
dc.contributor.authorMonireh Khanzadeh-
dc.contributor.authorNegar Jafari-
dc.contributor.authorShokoufeh Khanzadeh-
dc.date.accessioned2024-07-12T00:24:44Z-
dc.date.available2024-07-12T00:24:44Z-
dc.date.issued2024-05-28-
dc.identifier.issn1471-2261-
dc.identifier.urihttps://hdl.handle.net/20.500.12439/2736-
dc.description.abstractIn the current systematic review and meta-analysis, we aim to analyze the existing literature to evaluate the role of inflammatory biomarkers, including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), C-reactive protein (CRP), tumor necrosis factor-a (TNF-a), and interleukin-6 (IL-6) among individuals with cardiac syndrome X (CSX) compared to healthy controls.-
dc.titleInflammatory biomarkers in cardiac syndrome X: a systematic review and meta-analysis-
dc.typeJournal article-
dcterms.accessRightsFree article-
dc.description.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/38807048/-
dc.identifier.doi10.1186/s12872-024-03939-3-
dc.identifier.journaltitleBMC Cardiovascular Disorders-
dc.type.studyortrialSystematic review and/or meta-analysis-
dc.subject.keywordsBiomarker-
dc.subject.keywordsCardiac syndrome X-
dc.contributor.nhauthorShirin Sarejloo-
dc.description.nhaffiliation(Sarejloo) Northern Health, Melbourne, VIC, Australia-
Appears in Collections:Articles

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.